GREGORY MCCORD
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology
- Where
- MORGANFIELD, KY
- NPI
- 1720116924
- Received
- $78,500 in 221 records, 2019 to 2025 ($3,548 general, $74,952 research)
- As principal investigator
- $170,009 of research payments to others in 15 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 35 | $548 |
| 2024 | General payment | 47 | $887 |
| 2023 | General payment | 22 | $378 |
| 2022 | General payment | 19 | $316 |
| 2021 | General payment | 31 | $446 |
| 2021 | Research payment | 1 | $3,160 |
| 2020 | General payment | 36 | $569 |
| 2020 | Research payment | 2 | $15,524 |
| 2019 | General payment | 26 | $401 |
| 2019 | Research payment | 2 | $56,268 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Eli Lilly and Company | 5 | $74,952 | 2019–2021 |
| ABBVIE INC. | 122 | $1,595 | 2019–2025 |
| Janssen Biotech, Inc. | 25 | $679 | 2020–2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $348 | 2019–2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $182 | 2019–2025 |
| PFIZER INC. | 6 | $127 | 2023–2025 |
| IRONWOOD PHARMACEUTICALS, INC | 7 | $123 | 2019–2020 |
| Lilly USA, LLC | 5 | $90 | 2023–2025 |
| Gilead Sciences, Inc. | 4 | $77 | 2020–2023 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $56 | 2022 |
| Allergan, Inc. | 4 | $52 | 2019–2020 |
| Celgene Corporation | 3 | $48 | 2023–2024 |
| Ardelyx, Inc. | 2 | $38 | 2025 |
| Echosens North America, Inc. | 1 | $36 | 2021 |
| Merck Sharp & Dohme LLC | 2 | $36 | 2020–2021 |
| Intercept Pharmaceuticals, Inc. | 2 | $33 | 2021 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 5 | $74,952 |
| Food and Beverage | 215 | $3,464 |
| Education | 1 | $84 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-12-18 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-12-17 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-12-01 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-11-26 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-11-21 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-11-20 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-11-17 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | VELSIPITY Drug, INFLAMMATION;PAIN | 2025 | |
| 2025-11-14 | Ardelyx, Inc. | $17 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2025 | |
| 2025-11-03 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-10-23 | Janssen Biotech, Inc. | $26 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-10-23 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-21 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-09-16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2025 | |
| 2025-09-12 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-08-26 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-08-18 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2025 | |
| 2025-08-08 | Ardelyx, Inc. | $21 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2025 | |
| 2025-07-24 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-07-22 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-06-30 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2025 | |
| 2025-06-30 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-20 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-06-17 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-06-02 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-05-20 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-03-20 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-02-24 | PFIZER INC. | $28 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2025 | |
| 2025-02-03 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-01-30 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-01-27 | Janssen Biotech, Inc. | $21 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-01-21 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-01-13 | Janssen Biotech, Inc. | $20 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-01-13 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-01-09 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | ENTYVIO Biological, INTERNAL MEDICINE | 2025 | |
| 2024-12-16 | Janssen Biotech, Inc. | $17 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-12-16 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-12-07 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-12-02 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2024 | |
| 2024-11-04 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-10-31 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-10-20 | Janssen Biotech, Inc. | $21 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-10-14 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-09-19 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-09-19 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2024 | |
| 2024-09-09 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2024 | |
| 2024-08-29 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-08-19 | Janssen Biotech, Inc. | $23 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-08-19 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2024 | |
| 2024-08-12 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-08-08 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-08-05 | Janssen Biotech, Inc. | $84 | Education | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-08-05 | Janssen Biotech, Inc. | $27 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-07-29 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2024 | |
| 2024-07-08 | Janssen Biotech, Inc. | $28 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-06-28 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-06-17 | Takeda Pharmaceuticals U.S.A., Inc. | $19 | Food and Beverage | In-kind items and services | EOHILIA Drug, INTERNAL MEDICINE | 2024 | |
| 2024-06-14 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-06-03 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-06-03 | Celgene Corporation | $14 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-05-22 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-05-21 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2024 | |
| 2024-05-20 | Regeneron Healthcare Solutions, Inc. | $22 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-05-13 | Janssen Biotech, Inc. | $31 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-05-09 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2024 | |
| 2024-05-08 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-05-07 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-04-30 | Janssen Biotech, Inc. | $30 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-04-20 | Janssen Biotech, Inc. | $20 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-04-18 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2024 | |
| 2024-04-13 | Janssen Biotech, Inc. | $34 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-04-08 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2024 | |
| 2024-03-26 | Janssen Biotech, Inc. | $29 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-03-22 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-03-20 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-03-04 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-03-04 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2024 | |
| 2024-02-01 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-01-26 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2024 | |
| 2024-01-22 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-01-18 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-01-10 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2023-12-18 | Janssen Biotech, Inc. | $29 | Food and Beverage | In-kind items and services | REMICADE Biological, Immunology | 2023 | |
| 2023-12-14 | Celgene Corporation | $19 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-12-07 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-12-04 | Janssen Biotech, Inc. | $26 | Food and Beverage | In-kind items and services | REMICADE Biological, Immunology | 2023 | |
| 2023-11-13 | Janssen Biotech, Inc. | $32 | Food and Beverage | In-kind items and services | REMICADE Biological, Immunology | 2023 | |
| 2023-10-20 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-10-19 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-10-10 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-10-04 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-09-19 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2023 | |
| 2023-09-05 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2023 | |
| 2023-09-01 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VIBERZI Drug, GASTROENTEROLOGY | 2023 | |
| 2023-08-17 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2023 | |
| 2023-07-31 | Janssen Biotech, Inc. | $30 | Food and Beverage | In-kind items and services | REMICADE Biological, Immunology | 2023 | |
| 2023-06-15 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2023 | |
| 2023-05-01 | Gilead Sciences, Inc. | $24 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-01 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-03-22 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-03-16 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2023 | |
| 2023-03-09 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2023 | |
| 2023-01-19 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2023 | |
| 2023-01-18 | Gilead Sciences, Inc. | $14 | Food and Beverage | In-kind items and services | 2023 | ||
| 2022-12-15 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2022 | |
| 2022-12-15 | ABBVIE INC. | $0 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2022 | |
| 2022-11-21 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2022 | |
| 2022-09-01 | Bayer Healthcare Pharmaceuticals Inc. | $56 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2022 | |
| 2022-08-16 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2022 | |
| 2022-07-21 | Janssen Biotech, Inc. | $21 | Food and Beverage | In-kind items and services | REMICADE Biological, Immunology | 2022 | |
| 2022-06-30 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2022 | |
| 2022-06-16 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2022 | |
| 2022-06-01 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2022 | |
| 2022-05-17 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2022 | |
| 2022-04-21 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2022 | |
| 2022-04-09 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2022 | |
| 2022-03-23 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18 | Food and Beverage | In-kind items and services | TRULANCE Drug, Gastroenterology | 2022 | |
| 2022-03-02 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2022 | |
| 2022-02-16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16 | Food and Beverage | In-kind items and services | TRULANCE Drug, Gastroenterology | 2022 | |
| 2022-01-20 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2022 | |
| 2022-01-18 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2022 | |
| 2022-01-11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12 | Food and Beverage | In-kind items and services | TRULANCE Drug, Gastroenterology | 2022 | |
| 2022-01-07 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2022 | |
| 2021-12-16 | Echosens North America, Inc. | $36 | Food and Beverage | Cash or cash equivalent | FibroScan Device, Elastography | 2021 | |
| 2021-12-02 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2021 | |
| 2021-12-01 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2021 | |
| 2021-11-24 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2021 | |
| 2021-11-09 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2021 | |
| 2021-11-08 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2021 | |
| 2021-10-21 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2021 | |
| 2021-09-10 | Intercept Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 2021 | |
| 2021-09-10 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2021 | |
| 2021-08-27 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2021 | |
| 2021-08-25 | Eli Lilly and Company | $3,160 | Research payment | Cash or cash equivalent | A PHASE 3B, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO- AND ACTIVE- CONTROLLED TREAT-THROUGH STUDY OF MIRIKIZUMAB A | 2021 | |
| 2021-06-29 | Takeda Pharmaceuticals U.S.A., Inc. | $13 | Food and Beverage | In-kind items and services | ENTYVIO Biological, INTERNAL MEDICINE | 2021 | |
| 2021-06-18 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | GATTEX Drug, INTERNAL MEDICINE | 2021 | |
| 2021-05-04 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2021 | |
| 2021-05-03 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2021 | |
| 2021-04-30 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2021 | |
| 2021-04-14 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2021 | |
| 2021-04-01 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2021 | |
| 2021-03-24 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VIBERZI Drug, GASTROENTEROLOGY | 2021 | |
| 2021-03-17 | Gilead Sciences, Inc. | $19 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-03-17 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2021 | |
| 2021-03-10 | Merck Sharp & Dohme LLC | $12 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2021 | |
| 2021-03-03 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2021 | |
| 2021-03-03 | Intercept Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 2021 | |
| 2021-03-01 | Janssen Biotech, Inc. | $11 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2021 | |
| 2021-02-16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2021 | |
| 2021-02-08 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2021 | |
| 2021-02-03 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | MOTEGRITY Drug, INTERNAL MEDICINE | 2021 | |
| 2021-01-21 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2021 | |
| 2021-01-21 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2021 | |
| 2021-01-20 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2021 | |
| 2021-01-12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2021 | |
| 2020-12-09 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19 | Food and Beverage | In-kind items and services | XIFAXAN Drug, GASTROENTEROLOGY | 2020 | |
| 2020-11-30 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2020 | |
| 2020-11-20 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | 2020 | ||
| 2020-11-12 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-10-28 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15 | Food and Beverage | In-kind items and services | XIFAXAN Drug, GASTROENTEROLOGY | 2020 | |
| 2020-10-26 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-10-26 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-10-14 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | 2020 | ||
| 2020-10-07 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2020 | |
| 2020-10-05 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2020 | |
| 2020-09-29 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-09-21 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2020 | |
| 2020-09-14 | Janssen Biotech, Inc. | $13 | Food and Beverage | In-kind items and services | REMICADE Biological, Immunology | 2020 | |
| 2020-09-09 | IRONWOOD PHARMACEUTICALS, INC | $19 | Food and Beverage | Cash or cash equivalent | Linzess Drug, GI | 2020 | |
| 2020-08-26 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2020 | |
| 2020-08-24 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2020 | |
| 2020-08-14 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-08-12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18 | Food and Beverage | In-kind items and services | XIFAXAN Drug, GASTROENTEROLOGY | 2020 | |
| 2020-08-12 | Takeda Pharmaceuticals U.S.A., Inc. | $13 | Food and Beverage | In-kind items and services | MOTEGRITY Drug, INTERNAL MEDICINE | 2020 | |
| 2020-08-05 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2020 | |
| 2020-08-03 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-07-22 | IRONWOOD PHARMACEUTICALS, INC | $15 | Food and Beverage | Cash or cash equivalent | Linzess Drug, GI | 2020 | |
| 2020-07-08 | Gilead Sciences, Inc. | $19 | Food and Beverage | In-kind items and services | 2020 | ||
| 2020-06-24 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-06-10 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2020 | |
| 2020-06-02 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-04-27 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-04-22 | Janssen Biotech, Inc. | $37 | Food and Beverage | In-kind items and services | REMICADE Biological, Immunology | 2020 | |
| 2020-04-15 | Allergan, Inc. | $15 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2020 | |
| 2020-03-25 | Allergan, Inc. | $12 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2020 | |
| 2020-03-13 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-03-11 | IRONWOOD PHARMACEUTICALS, INC | $18 | Food and Beverage | Cash or cash equivalent | Linzess Drug, GI | 2020 | |
| 2020-03-10 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-01-28 | Eli Lilly and Company | $3,856 | Research payment | In-kind items and services | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE E | 2020 | |
| 2020-01-27 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-01-13 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2020 | |
| 2020-01-08 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | 2020 | ||
| 2020-01-07 | Eli Lilly and Company | $11,668 | Research payment | Cash or cash equivalent | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE E | 2020 | |
| 2019-12-20 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | Humira Biological, Immunology | 2019 | |
| 2019-12-20 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | Humira Biological, Immunology | 2019 | |
| 2019-11-25 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | Humira Biological, Immunology | 2019 | |
| 2019-11-14 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | Motegrity Drug, Lower GI | 2019 | |
| 2019-10-23 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | Humira Biological, Immunology | 2019 | |
| 2019-10-16 | Takeda Pharmaceuticals U.S.A., Inc. | $13 | Food and Beverage | In-kind items and services | Motegrity Drug, Lower GI | 2019 | |
| 2019-09-09 | Eli Lilly and Company | $52,793 | Research payment | Cash or cash equivalent | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE E | 2019 |
The latest 200 records of 221.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2023-02-23 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $70 | A PHASE 3 MULTICENTER OPEN LABEL LONG TERM EXTENSION STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF MIRIKIZUMAB | 2023 |
| 2023-01-03 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $5,197 | A PHASE 3 MULTICENTER OPEN LABEL LONG TERM EXTENSION STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF MIRIKIZUMAB | 2023 |
| 2023-01-01 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $70 | A PHASE 3 MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO- AND ACTIVE- CONTROLLED TREAT-THROUGH STUDY TO EVALUATE THE EFFICA | 2023 |
| 2022-02-23 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $741 | A PHASE 3, MULTICENTER, OPEN LABEL, LONG TERM EXTENSION STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF MIRIKIZUM | 2022 |
| 2022-02-14 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $44,304 | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE E | 2022 |
| 2022-01-26 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $270 | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE E | 2022 |
| 2022-01-04 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $15,165 | A PHASE 3, MULTICENTER, OPEN LABEL, LONG TERM EXTENSION STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF MIRIKIZUM | 2022 |
| 2021-03-02 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $16,966 | A PHASE 3, MULTICENTER, OPEN LABEL, LONG TERM EXTENSION STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF MIRIKIZUM | 2021 |
| 2021-02-23 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $4,577 | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE E | 2021 |
| 2021-02-02 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $34,211 | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE E | 2021 |
| 2021-01-06 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $975 | A PHASE 3, MULTICENTER, OPEN LABEL, LONG TERM EXTENSION STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF MIRIKIZUM | 2021 |
| 2020-12-09 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $161 | A PHASE 3, MULTICENTER, OPEN LABEL, LONG TERM EXTENSION STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF MIRIKIZUM | 2020 |
| 2020-03-23 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $293 | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE E | 2020 |
| 2020-01-28 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $46,986 | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE E | 2020 |
| 2019-06-20 | Eli Lilly and Company | QUALMEDICA RESEARCH LLC | $20 | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE E | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Morganfield, KY, county Union County, KY, state Kentucky; placed by its city name.
| Measure | Place (city or town) Morganfield, KY | County Union County, KY | State Kentucky |
|---|---|---|---|
| Population B01003 | 3,185 | 13,260 | 4,534,824 |
| Population, 2020 census P1 | 3,256 | 13,668 | 4,505,836 |
| Median age B01002 | 45.9 | 42.4 | 39.1 |
| Under 18 B01001 | 18.7% | 18.8% | 22.6% |
| 65 and over B01001 | 26.3% | 19.8% | 17.3% |
| Households B11001 | 1,331 | 5,198 | 1,814,469 |
| Foreign born B05002 | 0.4% | 0.6% | 4.7% |
| Median household income B19013 | $65,829 | $60,327 | $63,726 |
| Median family income B19113 | $77,764 | $72,672 | $81,505 |
| Per capita income B19301 | $36,240 | $30,559 | $35,821 |
| Poverty rate B17001 | 15.9% | 18.4% | 16.1% |
| Unemployment rate B23025 | 0.4% | 2.7% | 4.9% |
| Civilian labor force B23025 | 1,301 | 5,795 | 2,152,038 |
| Mean commute (minutes) B08013 | 19.0 | 22.1 | 24.0 |
| Bachelor's degree or higher B15003 | 17.4% | 13.1% | 27.6% |
| Housing units B25001 | 1,630 | 5,846 | 2,023,116 |
| Owner-occupied B25003 | 57.3% | 70.2% | 68.3% |
| Renters B25003 | 42.7% | 29.8% | 31.7% |
| Median home value B25077 | $113,600 | $104,500 | $205,600 |
| Median gross rent B25064 | $852 | $790 | $967 |
| White, not Hispanic B03002 | 85.8% | 88.1% | 81.5% |
| Black B03002 | 9.8% | 6.9% | 7.6% |
| Hispanic or Latino B03002 | 0.9% | 1.7% | 5.0% |
| Asian B03002 | 0.0% | 0.1% | 1.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Economy now FRED unemployment 4.7% in Sep 2026 (4.5% a year earlier); per capita personal income $60,835 in 2025, up 29% in five years (+3.9% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Morganfield, KY.
Comments